Tympanogen
Parastoo Khoshakhlagh, Ph.D. is the CEO & Co-Founder at GC Therapeutics and a Member of the Board Of Directors & Co-Founder at Tympanogen. Parastoo has experience as a Postdoctoral Research Fellow at Wyss Institute for Biologically Inspired Engineering, Harvard Medical School, and Harvard-MIT Health Sciences and Technology. Parastoo holds a Ph.D. in Biomedical Engineering/Neural Engineering from Tulane University.
This person is not in any teams
This person is not in any offices
Tympanogen
Tympanogen develops novel materials to improve treatment outcomes and decrease healthcare costs for otolaryngologists and their patients. Its flagship product, Perf-Fix, is the first gel patch for nonsurgical eardrum repair.